This topic contains a solution. Click here to go to the answer

Author Question: An donee beneficiary is best described as a person: A) whom parties intended to benefit. B) who is a ... (Read 88 times)

Sufayan.ah

  • Hero Member
  • *****
  • Posts: 512
An donee beneficiary is best described as a person:
 A) whom parties intended to benefit.
 B) who is a third-party beneficiary and for whom performance is a gift.
 C) to whom the promisee owes an obligation or duty.
 D) who unintentionally benefits from performance of contract.

Question 2

An assignment of royalties to a song:
 A)is a contract.
 B) requires consideration.
 C) is a transfer of rights.
 D) is not enforceable.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

covalentbond

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

B

Answer to Question 2

C




Sufayan.ah

  • Member
  • Posts: 512
Reply 2 on: Jun 24, 2018
Great answer, keep it coming :)


miss.ashley

  • Member
  • Posts: 371
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

For a complete list of videos, visit our video library